erlotinib hydrochloride has been researched along with hydrocortisone acetate in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (hydrocortisone acetate) | Trials (hydrocortisone acetate) | Recent Studies (post-2010) (hydrocortisone acetate) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 538 | 42 | 39 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chanprapaph, K; Pongcharoen, P; Vachiramon, V | 1 |
1 other study(ies) available for erlotinib hydrochloride and hydrocortisone acetate
| Article | Year |
|---|---|
Papulopustular eruptions in a 32-year-old woman after lung cancer treatment.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Antineoplastic Agents; Dermatologic Agents; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Hydrocortisone; Lung Neoplasms; Metronidazole; Mupirocin; Quinazolines | 2011 |